Predicting Lymph Node Metastases in Early Esophageal Adenocarcinoma Using a Simple Scoring System

被引:79
|
作者
Lee, Lawrence [1 ]
Ronellenfitsch, Ulrich [2 ]
Hofstetter, Wayne L. [4 ]
Darling, Gail [5 ]
Gaiser, Timo [3 ]
Lippert, Christiane [3 ]
Gilbert, Sebastien [6 ]
Seely, Andrew J. [6 ]
Mulder, David S. [1 ]
Ferri, Lorenzo E. [1 ]
机构
[1] McGill Univ, Ctr Hlth, Montreal, PQ H3G 1A4, Canada
[2] Univ Med Ctr Mannheim, Dept Surg, Mannheim, Germany
[3] Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany
[4] MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX USA
[5] Univ Hlth Network, Div Thorac Surg, Toronto, ON, Canada
[6] Ottawa Hosp, Div Thorac Surg, Ottawa, ON, Canada
关键词
HIGH-GRADE DYSPLASIA; ENDOSCOPIC MUCOSAL RESECTION; OPERATIVE MORTALITY; CARCINOMA; CANCER; IMPUTATION; OUTCOMES; VALUES; EMR;
D O I
10.1016/j.jamcollsurg.2013.03.015
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Endoscopic resection is an organ-sparing option for early esophageal adenocarcinoma, but should be used only in patients with a negligible risk of lymph node metastases (LNM). The objective was to develop a simple scoring system to predict LNM in T1 esophageal adenocarcinoma. STUDY DESIGN: All primary esophagectomies performed for T1 esophageal adenocarcinoma without neoadjuvant therapy at 5 university institutions from 2000 to 2011 were analyzed. Patient and pathologic characteristics were compared between patients with LNM at the time of surgical resection and those without. Univariate and multivariate analyses were performed to establish a simple scoring system that estimated the risk of LNM, using variables from the final surgical pathology. RESULTS: A total of 258 patients were included for analysis (mean age 65.2 years [SD 10.3 years], 88% male). The incidence of LNM was 7% (9 of 122) for T1a and 26% (35 of 136) for T1b. Tumor size (odds ratio [OR] 1.35 per cm, 95% CI 1.07 to 1.71) and lymphovascular invasion (OR 7.50, 95% CI 3.30 to 17.07) were the strongest independent predictors of LNM. A weighted scoring system was devised from the final multivariate model and included size (+1 point per cm), depth of invasion (+2 for T1b), differentiation (+3 for each step of dedifferentiation), and lymphovascular invasion (+6 if present). Total number of points estimated the probability of LNM (low risk [0 to 1 point], <= 2%; moderate risk [2 to 4 points], 3% to 6%; and high risk [5+ points], >= 7%). CONCLUSIONS: We devised a simple scoring system that accurately estimates the risk of LNM to aid in decision-making in patients with T1 esophageal adenocarcinoma undergoing endoscopic resection. (C) 2013 by the American College of Surgeons
引用
收藏
页码:191 / 199
页数:9
相关论文
共 50 条
  • [11] Identifying Biomarkers in Lymph Node Metastases of Esophageal Adenocarcinoma for Tumor-Targeted Imaging
    de Gouw, D. J. J. M.
    Rijpkema, M.
    de Bitter, T. J. J.
    Baart, V. M.
    Sier, C. F. M.
    Hernot, S.
    van Dam, G. M.
    Nagtegaal, I. D.
    Klarenbeek, B. R.
    Rosman, C.
    van der Post, R. S.
    MOLECULAR DIAGNOSIS & THERAPY, 2020, 24 (02) : 191 - 200
  • [12] The value of endoscopic ultrasound to distinguish the number of lymph node metastases in patients with esophageal adenocarcinoma
    Leers, Jessica M.
    Hagen, Jeffrey A.
    Ayazi, Shahin
    Oezcelik, Arzu
    Abate, Emmanuele
    Banki, Farzaneh
    Lipham, John C.
    DeMeester, Steven R.
    DeMeester, Tom R.
    GASTROENTEROLOGY, 2008, 134 (04) : A884 - A884
  • [13] Prediction of Lymph Node Metastases via PET Radiomics of Primary Tumour in Esophageal Adenocarcinoma
    Shi, Z.
    Zhang, C.
    Kalendralis, P.
    Whybra, P.
    Parkinson, C.
    Berbee, M.
    Spezi, E.
    Roberts, A.
    Christian, A.
    Crosby, T.
    Dekker, A.
    Wee, L.
    Foley, K. G.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S827 - S828
  • [14] Establishment and Validation for Predicting the Lymph Node Metastasis in Early Gastric Adenocarcinoma
    Li, Xuan
    Zhou, Haiyan
    Zhao, Xianhui
    Peng, Huan
    Luo, Shanshan
    Feng, Juan
    Heng, Jianfu
    Liu, Heli
    Ge, Jie
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [15] Molecular markers predicting lymph node metastasis in early esophageal cancer
    Plum, Patrick S.
    Warnecke-Eberz, Ute
    Dhaouadi, Oulfa
    Alakus, Hakan
    Drebber, Uta
    Metzger, Ralf
    Prenzel, Klaus L.
    Hoelscher, Arnulf H.
    Bollschweiler, Elfriede
    HISTOLOGY AND HISTOPATHOLOGY, 2015, 30 (10) : 1193 - 1202
  • [16] Dissection of lymph node metastases in esophageal cancer
    Gockel, Ines
    Sgourakis, George
    Lyros, Orestis
    Hansen, Torsten
    Lang, Hauke
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (04) : 571 - 578
  • [17] Detection of lymph node metastases in esophageal cancer
    Sgourakis, George
    Gockel, Ines
    Lyros, Orestis
    Hansen, Torsten
    Mildenberger, Peter
    Lang, Hauke
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (04) : 601 - 612
  • [18] CONTRIBUTION OF A RISK SCORING SYSTEM FOR EVALUATING THE RISK OF LYMPH NODE METASTASES IN EARLY-STAGE ENDOMETRIAL CANCER
    Bendifallah, S.
    Darai, E.
    Ballester, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 232 - 232
  • [19] Distribution of lymph nodes and lymph node metastases in esophageal cancer
    Fraunberger, L
    Kraus, B
    Dworak, O
    ZENTRALBLATT FUR CHIRURGIE, 1996, 121 (02): : 102 - 105
  • [20] A Simple Scoring System Predicts Which Patients with Esophageal Cancer Benefit from Endoscopic Ultrasound for Lymph Node Classfication
    Zuccaro, Gregory
    Rice, Thomas W.
    Vargo, John J.
    Dumot, John A.
    Stevens, Tyler
    Lopez, Rocio
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (05) : AB128 - AB129